Positron announces opening of Clinical and Technical Cardiovascular PET Training Institute

Positron Corporation (OTCBB:POSC), a molecular imaging company specializing in Nuclear Cardiology and a leader in Cardiac PET, announced today the grand opening of its Clinical and Technical Cardiovascular PET Training Institute in Niagara Falls, NY.

The training center will educate physicians, technologists, nurses and administrators on the use and benefits of cardiac PET imaging in the daily operations of their facility.  The training will be done in a partnership with the Heart Center of Niagara where Positron's medical director, Michael E. Merhige, M.D., F.A.C.C currently operates a Coronary Artery Disease Reversal and Prevention Center guided by Positron PET imaging technologies. 

Positron's chief technical officer, Joe Oliverio, stated, "This center will be a critical tool in building awareness of the tangible benefits a dedicated cardiac PET scanner yields.  Creating a center specifically geared towards disseminating information is critically important as we work to grow the adaptation of PET scanners into the medical imaging marketplace.  As an early adaptor of cardiac PET imaging, Dr. Merhige is an ideal ambassador to the medical community; tapping into the combined decades of experience Dr. Merhige and Positron's clinical staff possess, will allow a seamless transition of users from SPECT to PET."

Dr. Michael E. Merhige said, "Cardiac PET has been around since 1995, but only until very recently has the necessary peer-reviewed literature been available to allow for its proper recognition.  PET scanning for cardiac use exposes the patient to significantly reduced levels of radiation, compared to SPECT, while affording physicians a highly effective diagnostic tool.  I am pleased to play a role in educating my peers on the benefits of a cardiac PET scanner."